95 related articles for article (PubMed ID: 8091394)
1. Platelet shape change in whole blood: differential effects of endotoxin.
Nystrom ML; Barradas MA; Jeremy JY; Mikhailidis DP
Thromb Haemost; 1994 May; 71(5):646-50. PubMed ID: 8091394
[TBL] [Abstract][Full Text] [Related]
2. Doxazosin, an alpha1-adrenoceptor antagonist, inhibits serotonin-induced shape change in human platelets.
Jagroop IA; Mikhailidis DP
J Hum Hypertens; 2001 Mar; 15(3):203-7. PubMed ID: 11317206
[TBL] [Abstract][Full Text] [Related]
3. [The thrombocyte-activation factor and endotoxin-induced thrombocyte activation].
Lomazova KD; Poliakova AM; Astrina OS; Tsukerman DB
Biull Eksp Biol Med; 1989 May; 107(5):538-40. PubMed ID: 2500157
[TBL] [Abstract][Full Text] [Related]
4. The role of thromboxane A2 in endotoxin-induced aggregation of guinea-pig platelets in vitro.
Bult H; Herman AG
Agents Actions Suppl; 1979; (4):147-55. PubMed ID: 386740
[TBL] [Abstract][Full Text] [Related]
5. Platelet activating factor enhancement of lipopolysaccharide-induced tissue factor activity in monocytes: requirement of platelets and granulocytes.
Osterud B
J Leukoc Biol; 1992 May; 51(5):462-5. PubMed ID: 1602239
[TBL] [Abstract][Full Text] [Related]
6. The effect of tirofiban on fibrinogen/agonist-induced platelet shape change and aggregation.
Jagroop IA; Mikhailidis DP
Clin Appl Thromb Hemost; 2008 Jul; 14(3):295-302. PubMed ID: 18445610
[TBL] [Abstract][Full Text] [Related]
7. Lipopolysaccharide-stimulated leukocytes contribute to platelet aggregative dysfunction, which is attenuated by catalase in rats.
Dong HP; Chunag IC; Wang DC; Huang LJ; Lee CI; Tsai JH; Yang RC
Kaohsiung J Med Sci; 2010 Nov; 26(11):584-92. PubMed ID: 21126711
[TBL] [Abstract][Full Text] [Related]
8. Measurement of platelet volume using a channelyzer: assessment of the effect of agonists and antagonists.
Barradas MA; O'Donoghue S; Mikhailidis DP
In Vivo; 1992; 6(6):629-34. PubMed ID: 1296813
[TBL] [Abstract][Full Text] [Related]
9. Roles of thromboxane A2 and 5-hydroxytryptamine in endotoxin-induced digital vasoconstriction in horses.
Menzies-Gow NJ; Sepulveda MF; Bailey SR; Cunningham FM; Elliott J
Am J Vet Res; 2008 Feb; 69(2):199-207. PubMed ID: 18241016
[TBL] [Abstract][Full Text] [Related]
10. Role of thromboxane A2 and platelet activating factor in early haemodynamic response to lipopolysaccharide in rats.
Bocheński J; Chłopicki S; Gryglewski RJ
J Physiol Pharmacol; 1999 Jun; 50(2):287-97. PubMed ID: 10424723
[TBL] [Abstract][Full Text] [Related]
11. Bartonella quintana lipopolysaccharide effects on leukocytes, CXC chemokines and apoptosis: a study on the human whole blood and a rat model.
Matera G; Liberto MC; Quirino A; Barreca GS; Lamberti AG; Iannone M; Mancuso E; Palma E; Cufari FA; Rotiroti D; Focà A
Int Immunopharmacol; 2003 Jun; 3(6):853-64. PubMed ID: 12781702
[TBL] [Abstract][Full Text] [Related]
12. Endotoxin-induced pulmonary leukostasis in the rat: role of platelet-activating factor and tumor necrosis factor.
Chang SW
J Lab Clin Med; 1994 Jan; 123(1):65-72. PubMed ID: 8288963
[TBL] [Abstract][Full Text] [Related]
13. Epinephrine promotes IL-8 production in human leukocytes via an effect on platelets.
Engstad CS; Lund T; Osterud B
Thromb Haemost; 1999 Jan; 81(1):139-45. PubMed ID: 10348705
[TBL] [Abstract][Full Text] [Related]
14. Role of platelet activating factor in development of thrombocytopenia and neutropenia in dogs with endotoxemia.
Tsuchiya R; Kyotani K; Scott MA; Nishizono K; Ashida Y; Mochizuki T; Kitao S; Yamada T; Kobayashi K
Am J Vet Res; 1999 Feb; 60(2):216-21. PubMed ID: 10048555
[TBL] [Abstract][Full Text] [Related]
15. Platelet-platelet and platelet-leukocyte interactions induced by outer membrane vesicles from N. meningitidis.
Mirlashari MR; Hagberg IA; Lyberg T
Platelets; 2002 Mar; 13(2):91-9. PubMed ID: 11897045
[TBL] [Abstract][Full Text] [Related]
16. Agonists of toll-like receptor (TLR)2 and TLR4 are unable to modulate platelet activation by adenosine diphosphate and platelet activating factor.
Ward JR; Bingle L; Judge HM; Brown SB; Storey RF; Whyte MK; Dower SK; Buttle DJ; Sabroe I
Thromb Haemost; 2005 Oct; 94(4):831-8. PubMed ID: 16270639
[TBL] [Abstract][Full Text] [Related]
17. Regulation of platelet activating factor-induced equine platelet activation by intracellular kinases.
Brooks AC; Menzies-Gow NJ; Wheeler-Jones CP; Bailey SR; Elliott J; Cunningham FM
J Vet Pharmacol Ther; 2009 Apr; 32(2):189-96. PubMed ID: 19290950
[TBL] [Abstract][Full Text] [Related]
18. An investigation into the effects of bacterial lipopolysaccharide on human platelets.
Whitworth NH; Barradas MA; Mikhailidis DP; Dandona P
Eur J Haematol; 1989 Aug; 43(2):112-9. PubMed ID: 2792318
[TBL] [Abstract][Full Text] [Related]
19. Effect of lipoprotein (a) on platelet activation induced by platelet-activating factor: role of apolipoprotein (a) and endogenous PAF-acetylhydrolase.
Tsironis LD; Mitsios JV; Milionis HJ; Elisaf M; Tselepis AD
Cardiovasc Res; 2004 Jul; 63(1):130-8. PubMed ID: 15194469
[TBL] [Abstract][Full Text] [Related]
20. Increased platelet purinergic sensitivity in peripheral arterial disease--a pilot study.
Braun OO; Jagroop A; Wang L; Mikhailidis DP; Burnstock G; Erlinge D
Platelets; 2005 Aug; 16(5):261-7. PubMed ID: 16011976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
